Schedule 13G ownership disclosure

Black Diamond Therapeutics Inc

Common Stock · CUSIP: 09203E105

Event date: 2025-03-31

Filing-level shares
2,523,521.00
Percent of class
4.5%
  • BlackRock, Inc.

    Shares: 2,523,521.00 · Class: 4.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-001839
Form type
SCHEDULE 13G/A
Filer
Black Diamond Therapeutics, Inc.
CIK
CIK 1701541
Filed
Apr 29, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub